From owner-diagnostics@net.bio.net Sun Feb 02 22:00:00 1997 Path: biosci!biosci!not-for-mail From: BIOSCI Administrator Newsgroups: bionet.diagnostics Subject: BIOSCI/bionet miniFAQ & Fundraiser Date: 3 Feb 1997 02:09:20 -0800 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 239 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5d4dgg$i87@net.bio.net> NNTP-Posting-Host: net.bio.net (LAST REVISION: 30-JUL-95) This BIOSCI "miniFAQ" is designed to answer the questions that come up the *most frequently*. The main BIOSCI FAQ (Frequently Asked Questions) is accessible on the World Wide Web at URL http://www.bio.net/. If you can not find an answer to your question in this or other documentation, the BIOSCI technical support staff answers e-mail queries sent to biosci-help@net.bio.net We can only answer questions about the use of the newsgroups and mailing lists. We unfortunately do not have the staff to do Internet information searches or answer scientific questions. Please post those to the appropriate BIOSCI/bionet newsgroups. Contents: -------- 0) BIOSCI NEEDS YOUR SUPPORT!! 1) Using the WWW to access the BIOSCI/bionet newsgroups. 2) What to do about "spams," i.e., junk mail, ads, etc. 3) Examples of subscribing and unsubscribing to the mailing lists. 4) The BIOSCI user address and research interest directory. 0) BIOSCI NEEDS YOUR SUPPORT!! ------------------------------ BIOSCI's government funding has been expended, and we are now operating solely from advertising revenue that we have raised from our Web site at http://www.bio.net/. We need just a few minutes of your time to help us serve you. You can do two important things which will take very little time for you individually and will immensely help us continue to help you. First, please use our WWW system at http://www.bio.net/ to access the archives. You can post or reply to messages via your Web browser as described in item #1 below. Your usage helps attract sponsors. If you contact any of our sponsors, please be sure to thank them for supporting BIOSCI. It is critical for them to get this feedback if they are to continue their sponsorship for the long term. Second, if you work for a company or organization that provides products or services of interest to the biology community, please pass this message on to your marketing or marketing communications department or other appropriate group. Please ask them to help support BIOSCI by sponsoring our Web site and explain the uses and benefits of the system to the biology community. If they are interested, they can then contact us for further information at our tech support address, biosci-help@net.bio.net. 1) Using the WWW to access the BIOSCI/bionet newsgroups. -------------------------------------------------------- As of 10 December 1995, all BIOSCI/bionet full newsgroups are accessible through the World Wide Web (WWW) at URL http://www.bio.net. One can read and reply publicly or privately to both recent postings and archived messages through one's Web browser if it is configured properly to send e-mail. Each newsgroup is equipped with its own WAIS index. The main BIOSCI home page also has access to the BIO-JOURNALS Table of Contents database WAIS index and the BIOSCI user address database described in another item further below. 2) What to do about "spams," i.e., junk mail, ads, etc. ------------------------------------------------------- BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups), mailing lists, and a hypermail archive at URL http://www.bio.net/. The same postings are distributed on all media (except for a small number of mailing-list-only groups at net.bio.net). Unfortunately it is becoming a despicable practice on the Internet (by a few people out to make a fast buck) to do automated mass postings to thousands of newsgroups and mailing lists. These attempts to grab free advertising are refered to as "spams" in the usual, somewhat boneheaded, net terminology. USENET is more susceptible to this practice, and many spams originate on the USENET groups and then are passed on to the mailing lists. However, spammers also get lists of mailing addresses and hit these too, so neither medium is immune. What should you do personally if you get junk mail? --------------------------------------------------- Just delete it and move on without reading it further. Filing a protest is becoming increasingly useless because spammers are often disguising the addresses where the messages are sent from. Unless you really understand Internet mail systems, your attempt at protest by sending replies to the message will often end up being sent to the address of an innocent person that the spammer is victimizing. What can BIOSCI/bionet do to protect its newsgroups? ---------------------------------------------------- The only solution currently available is to moderate the newsgroup. If this newsgroup is already moderated, then you are in good shape. Moderation protects the USENET distribution from about 95% of the spams that are being sent to date and protects the mailing lists completely. Moderation means, however, that someone has to take the time to review each message before it goes out. We have set up software here that simply allows the moderator to forward to an address at net.bio.net messages that (s)he wishes to have distributed. This takes no more time than that needed to read the message and pass it on, say about 1 min. per message. Most newsgroups currently have a discussion leader who is responsible for their newsgroup. The discussions leaders and their e-mail addresses are listed in the BIOSCI Information Sheet which is available on the Web at http://www.bio.net/. If a newsgroup is being hit with too many junk postings, please contact the discussion leader for that group and see if there is interest in moderating the group. Please do not assume that by simply posting a complaint to the newsgroup itself, anyone on the BIOSCI staff will act on your complaint. With close to 100 newsgroups to run, the BIOSCI staff has to rely on the discussion leaders of each newsgroup to report problems directly to us at biosci-help@net.bio.net. We will moderate any of our newsgroups if the discussion leader tells us that the readership of the group wishes to do so and if a moderator is willing to do the work. For most BIOSCI/bionet groups, this entails only a few minutes of work each day. Moderating a newsgroup will resolve probably 95% of the junk postings on the USENET distribution. Unfortunately there are easy ways for determined spammers to override the moderation mechanism on USENET, but we can protect our e-mail subscribers from unwanted postings if the newsgroup is moderated. You can also access our newsgroups over the WWW at URL http://www.bio.net. While this Web interface will not stop spammers from trying to post to the groups, this will give you yet another way, besides using USENET news, to keep the junk out of your personal mail files. For those of you with local USENET news systems, the Web interface will also give you faster access to new newsgroups and recent postings. 3) Examples of subscribing and unsubscribing to the mailing lists. ------------------------------------------------------------------ PLEASE NOTE: The BIOSCI management does NOT act on subscription/unsubscription requests that are posted improperly to the newsgroups and mailing lists. People who do this only bother everyone on the lists to no avail. Please be sure to follow the proper procedures below. Gory details are in the BIOSCI Information sheets on the Web at http://www.bio.net. Below we give an example utilizing the METHODS-AND-REAGENTS list at both of our two BIOSCI sites: Users in the Americas and Pacific Rim countries who use the BIOSCI ------------------------------------------------------------------ node at computer net.bio.net: ---------------------------- A) Determine the "listname" which is the <=8 character mail address ^^^^^^^^^^^^^ for the group. These can be found in the BIOSCI Info. Sheet. For the METHODS-AND-REAGENTS group the mailing address is methods@net.bio.net. The listname is the portion of the address to the left of the @ sign, i.e., "methods". The listname is used with the "subscribe" and "unsubscribe" commands illustrated below. B) Mail all commands in the body of a mail message addressed to biosci-server@net.bio.net. Do NOT send commands to the newsgroup posting addresses! Leave the Subject: line blank, any text on it will be ignored. C) In the body of your message put one or more of the following commands with an "end" command on the last line, e.g., subscribe methods unsubscribe methods end Do NOT put your e-mail address or other text on these lines. The server only allows you to cancel your subscription if the address on your mail header matches the address on our mailing list. Please ask for help at biosci-help@net.bio.net if your address has changed, e.g., if you know you are on the list but the server tells you that you are not a member. Users in Europe, Africa, and Central Asia who use the BIOSCI node at -------------------------------------------------------------------- computer daresbury.ac.uk (also known as dl.ac.uk): ------------------------------------------------- To subscribe and unsubscribe to/from the BIOSCI lists, you need to specify the full USENET newsgroup name with "bionet-news." prepended. The USENET newsgroup names are listed in the BIOSCI Information sheet on the Web at http://www.bio.net/. For the METHODS-AND-REAGENTS list the USENET newsgroup name is bionet.molbio.methds-reagnts, thus the appropriate commands are sub bionet-news.bionet.molbio.methds-reagnts unsub bionet-news.bionet.molbio.methds-reagnts These commands are included in a message addressed to mxt@dl.ac.uk, NOT to the newsgroup mailing addresses. As usual, include the text in the body of the message as text on the Subject: line is ignored. To unsubscribe from all the lists at the UK node, use unsub bionet-news Please note that if the address in the list is different than the one in your mail message header, you will not be able to unsubscribe by this method. If you have problems, please mail biosci@daresbury.ac.uk. 4) The BIOSCI user address and research interest directory. ----------------------------------------------------------- Please take this opportunity to add your name, address, and research interest information to the BIOSCI User Address Database if you have not already done so. You can fill out the address form directly through our Web page at URL http://www.bio.net/adrform.html. The address database is reindexed nightly for WWW access (the URL is http://www.bio.net/). If you are not directly on the Internet but can reach it by e-mail, please use our waismail server to access the user directory. waismail use is described above. You can also request a user address form by e-mail from biosci-help@net.bio.net. Please check your database entry from time-to-time to see if your address information is still up-to-date. Because of our limited personnel resources, we ask that you resubmit a *complete* form to revise your entry; we only replace complete entries and do not have resources to edit old forms. Sincerely, Dave Kristofferson BIOSCI/bionet Manager biosci-help@net.bio.net From owner-diagnostics@net.bio.net Tue Feb 04 22:00:00 1997 Path: biosci!biosci!not-for-mail From: "Carl M. Good III" Newsgroups: bionet.diagnostics Subject: Drugs of abuse testing Date: 5 Feb 1997 09:25:21 -0800 Organization: ITP Lines: 5 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5dafq1$pq1@net.bio.net> NNTP-Posting-Host: net.bio.net We are interested in drugs of abuse testing with a focus on saliva testing. We are also looking for distributors for a line of rapid urine tests. Thanks for your interest. Carl Good From owner-diagnostics@net.bio.net Tue Feb 04 22:00:00 1997 Path: biosci!biosci!not-for-mail From: "Dr. Carl Good" Newsgroups: bionet.diagnostics Subject: DOA rapid test distribution Date: 5 Feb 1997 09:28:50 -0800 Organization: Avitar Technologies Lines: 9 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5dag0i$qhe@net.bio.net> NNTP-Posting-Host: net.bio.net I am interested in the rapid point of care drug testing marketplace and am looking for distributors (world wide) for a line of rapid DOA tests that have 510k allowance for sale. Thanks for your help. Carl Good (carlg@ultranet.com) Avitar Corporation From owner-diagnostics@net.bio.net Wed Feb 05 22:00:00 1997 Path: biosci!biosci!not-for-mail From: mattp@gen-probe.com Newsgroups: bionet.diagnostics Subject: AMPLIFICATION Date: 6 Feb 1997 01:41:12 -0800 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 2 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5dc8vo$e8e@net.bio.net> NNTP-Posting-Host: net.bio.net Has anybody heard of TMA? How does it rate as an amplified diagnostic tool? From owner-diagnostics@net.bio.net Wed Feb 05 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Bob van Gemen Newsgroups: bionet.diagnostics Subject: Re: AMPLIFICATION Date: 6 Feb 1997 03:56:55 -0800 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 25 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5dcgu7$p78@net.bio.net> NNTP-Posting-Host: net.bio.net >Has anybody heard of TMA? How does it rate as an amplified diagnostic tool? > TMA (transcription mediated amplification) is identical to NASBA and both are isothermal amplification methods based on transcription. The transcription based amplification methods are extremely suited to amplify RNA sequences and result in huge amounts of single strand RNA amplification product. Both on TMA and NASBA there are many publications describing the use for research and clinical diagnostic purposes. In our hands the performance of NASBA is always as good as the performance of PCR. In many cases were the target molecule is an RNA or in cases were quantification played an important role the NASBA was often better than the RT-PCR. Bob van Gemen Groupleader Molecular Biology Organon Teknika Boseind 15 5281 RM Boxtel The Netherlands E-mail: bvgemen@am.otbc01.umc.akzonobel.nl From owner-diagnostics@net.bio.net Thu Feb 06 22:00:00 1997 Path: biosci!biosci!not-for-mail From: "Siamak P. Yazdankhah" Newsgroups: bionet.diagnostics Subject: PCR for staphylococci beta lactamase Date: 7 Feb 1997 04:42:51 -0800 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 10 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5df80b$cdo@net.bio.net> NNTP-Posting-Host: net.bio.net >Hi >Has anyone found a good PCR method for amplification of staphylococci >beta lactamase? Siamak P. Yazdankhah Department of Microbiology and Immunology Norwegian College of Veterinary Medicine From owner-diagnostics@net.bio.net Tue Feb 11 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Ssihouston Newsgroups: bionet.diagnostics Subject: JOB - Regulatory Affairs Specialist, Pharmaceuticals - Hous= Date: 12 Feb 1997 02:08:08 -0800 Organization: AOL http://www.aol.com Lines: 74 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5ds4q8$j76@net.bio.net> NNTP-Posting-Host: net.bio.net JOB TITLE SENIOR REGULATORY AFFAIRS SPECIALIST JOB ORDER NUMBER ARTWTX07 DEPARTMENT UNKNOWN REPORTS TO MS. CYNTHIA MOLINA JOB STATUS: DIRECT, FULL-TIME HIRE OR CONTRACT TO PERMANENT. PREFERENCE WILL BE GIVEN TO CONTRACT-TO-PERMANENT CANDIDATES. POSITION SUMMARY This Senior Regulatory Affairs Specialist will be responsible for coordinating and preparing NDA and IND regulatory submissions for oncologic and infectious disease products. Must be sufficiently familiar with clinical, pharmacological and CMC areas to provide regulatory guidance to members of the various operating groups. This scientist will be responsible for writing summary sections of the submissions and coordinating answers to FDA questions. Experience with European marketing submissions would be helpful. Excellent written and oral communications skills are required as are excellent organizational and program management skills. The successful candidates will be a company regulatory representative in direct and regular contact with the FDA. This position requires a Bachelor's or Master's Degree from an accredited, four-year university in biosciences and at least three, preferably five years of relevant regulatory affairs experience in a pharmaceutical company. PRINCIPLE RESPONSIBILITIES =B7 Prepare and submit regulatory documents to the FDA (IND and NDA). =B7 Read, understand, compile various regulatory reports from different fields and write appropriate regulatory summaries for submission to FDA. =B7 Interact with and facilitate communication between staff members worki= ng in clinical, pharmacological and chemistry fields so as to coordinate the coherent submission of regulatory reports and summaries. REQUIRED QUALIFICATIONS: =B7 Bachelor's of Arts or Science Degree (or higher) from an accredited, four-year university. Advanced degree is acceptable and preferred (MS). =B7 Minimum of 3 years of directly relevant work experience in a regulator= y affairs position in a pharmaceutical company. Five years experience is preferred. =B7 Excellent interpersonal skills, especially as they relate to the interaction with staffers in diverse scientific fields to include clinical, pharmacological and chemical disciplines. Also essential is the ability to effectively interact with physicians, other clinicians and members of the FDA and other governmental agencies. =B7 Computer literacy with PC systems using Microsoft Windows 3.1 and Windows `95 operating systems and extensive experience with PC based report writing via Microsoft Word and spreadsheet analysis using Microsoft Excel. =B7 Excellent verbal and particularly written communication skills require= d. This includes a requirement for excellent English grammar and diction. =B7 Ability to calmly handle stressful situations brought on by submission deadlines and the pressures inherent in a rapidly growing biotechnology company. =B7 Willingness to travel at least 10% of the time. PREFERRED QUALIFICATIONS: =B7 Supervisory experience or capabilities =B7 Project management skills =B7 Experience with European regulatory submissions =B7 Experience in an identical position with a major, domestic or western European pharmaceutical company. David W. Walters, Ph.D. Senior Scientific Recruiter ScienStaff, Inc. 7007 Gulf Freeway, Suite 239 Houston, Texas 77087 Phone: 713-640-1929 e-mail: ssihouston@aol.com From owner-diagnostics@net.bio.net Tue Feb 11 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Ssihouston Newsgroups: bionet.diagnostics Subject: JOB - Regulatory Affairs Direector, BioMedical Devices - Houston Date: 12 Feb 1997 02:06:43 -0800 Organization: AOL http://www.aol.com Lines: 14 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5ds4nj$iud@net.bio.net> NNTP-Posting-Host: net.bio.net Regulatory Affairs Officer, Director or Vice President, for biomedical device industry. Salary is competitive. Requires MD or Ph.D. This is a hands on position. There will be approximately 75% travel and extensive interfacing with multi-site clinical trial personnel to include vascular surgeons, internal radiologists and cardiologists. Must be intimately familiar with all forms of regulatory FDA submissions 510k, PMA, IND, IDE, NDA, etc. This position will have an assistant. David W. Walters, Ph.D. Senior Scientific Recruiter ScienStaff, Inc. 7007 Gulf Freeway, Suite 239 Houston, Texas 77087 Phone: 713-640-1929 e-mail: ssihouston@aol.com From owner-diagnostics@net.bio.net Sun Feb 16 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Eric Masseus <100577.3707@compuserve.com> Newsgroups: bionet.diagnostics Subject: Medical Technologists Date: 17 Feb 1997 01:38:35 -0800 Organization: Gooi-Noord Hospital, Dept Clin Chem, Netherlands Lines: 10 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5e98ur$n8e@net.bio.net> NNTP-Posting-Host: net.bio.net I'm looking for URL's concerning societies of medical laboratory technologists If you are familiar with such an URL ... please let me know The URL were you can find info on the Dutch Society of bioMedical Laboratory Technologists is http://ourworld.compuserve.com/homepages/Eric_Masseus_eforum/ Eric From owner-diagnostics@net.bio.net Sun Feb 16 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Ssihouston Newsgroups: bionet.diagnostics Subject: JOB - Senior R&D Disposables Engineer - Houston Date: 17 Feb 1997 01:55:34 -0800 Organization: AOL http://www.aol.com Lines: 54 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5e99um$pg8@net.bio.net> NNTP-Posting-Host: net.bio.net Responsibility / Scope: This position will report to the Director of Engineering. Your primary responsibility will be to design, develop and transfer to manufacturing a cost-effective disposable medical device. You will select the material. determine the form, design for manufacturability, verify performance and document the design process. You will work as a team member within the company and with our customers and partners. Design and Development Skills Required - Excellence in- Plastic Material Selection Injection Molded Part Design Optical engineering Design for Manufacturability Defining Customer Requirements Design Control Documentation Design Validation and Verification Experience with: Design of Experiments Computer Aided Design Finite Element Analysis Biocompatability and Sterilization European Medical Device Directives Background Requirements - 9 years of medical device experience successfully designing products for optical systems in a team environment. Compensation - We offer a competitive base salary and benefits and a relocation package. We are an equal opportunity employer. Location- We are located in Houston, Texas, home or the country's largest medical complex and one of the least expensive major metropolitan locations in the country. Please send curriculum vitae and list of references to: ScienStaff, Inc. Attn: Dr. David W. Walters, Ph.D. Senior Scientific Recruiter 7007 Gulf Freeway, Suite 239 Houston, TX 77087 No phone or FAX calls, please. David W. Walters, Ph.D. Senior Scientific Recruiter ScienStaff, Inc. 7007 Gulf Freeway, Suite 239 Houston, Texas 77087 Phone: 713-640-1929 e-mail: ssihouston@aol.com From owner-diagnostics@net.bio.net Sun Feb 16 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Ssihouston Newsgroups: bionet.diagnostics Subject: JOB - Senior Clinical Research Assoc., Therapeutics - Houst= Date: 17 Feb 1997 01:55:05 -0800 Organization: AOL http://www.aol.com Lines: 65 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5e99tp$pfb@net.bio.net> NNTP-Posting-Host: net.bio.net POSITION SUMMARY This Senior Clinical Research Associate will be responsible for the administration and monitoring of clinical trials for two developmental therapeutics; an antineoplastic and an HIV therapeutic. The successful candidate will have both protocol development experience and medical report experience as well as management, administrative and supervisory experience. Specific responsibilities include the management and supervision of more junior CRAs, protocol development, institutional and physician relations, clinical trial monitoring and the coordination of various in-house activities such a medical report writing. The ideal candidate will have both computer literacy, public relations and public presentation skills and project management skills. A minimum of 3 years of directly relevant experience is required, however, five years would be preferred. PRINCIPLE RESPONSIBILITIES =B7 Administration of clinical trials for two developmental therapeutic agents. =B7 Clinical trial protocol development. =B7 Medical report writing. =B7 Institutional and physician relations. =B7 Planning of the activities of and supervision of two more junior CRAs. =B7 Coordination of in-house activities such as report writing and presentations. =B7 Interaction with and presentations to corporate partners. REQUIRED QUALIFICATIONS: =B7 Bachelor's of Arts or Science Degree (or higher) from an accredited, four-year university. Advanced degree is preferred (M.S., Ph.D. or M.D.). =B7 Minimum of 2 years of directly relevant work experience in monitoring and administering clinical trials. Five years of experience is preferred. =B7 Excellent interpersonal skills, especially as they relate to the interaction with clinicians, facility administrators, investors and corporate partners. =B7 Computer literacy with PC systems using Microsoft Windows 3.1 and Windows `95 operating systems and extensive experience with PC based report writing. =B7 Willingness to travel at least 50% of the time. PREFERRED QUALIFICATIONS: =B7 Computer literacy with spreadsheets and databases (Microsoft Access). =B7 Proficiency with both written and spoken Spanish. =B7 Experience in an identical position with a major, domestic pharmaceutical company. Please send curriculum vitae and list of references to: ScienStaff, Inc. Attn: Dr. David W. Walters, Ph.D. Senior Scientific Recruiter 7007 Gulf Freeway, Suite 239 Houston, TX 77087 No phone or FAX calls, please. David W. Walters, Ph.D. Senior Scientific Recruiter ScienStaff, Inc. 7007 Gulf Freeway, Suite 239 Houston, Texas 77087 Phone: 713-640-1929 e-mail: ssihouston@aol.com From owner-diagnostics@net.bio.net Sun Feb 16 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Ssihouston Newsgroups: bionet.diagnostics Subject: JOB - Analytical Chemist, Therapeutics - Houston Date: 17 Feb 1997 01:56:04 -0800 Organization: AOL http://www.aol.com Lines: 31 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5e99vk$phe@net.bio.net> NNTP-Posting-Host: net.bio.net Leading Pharmaceutical Company is seeking an Analytical Chemist to develop methods for use in Quality Control and during drug development. Experience with chromatographic and spectroscopic techniques are a requirement, including HPLC, TLC, G.C., U.V., FTIR, and MS. Breadth of experience is a plus. The qualified candidate will have a Ph.D. in Analytical Chemistry, two to five years of pharmaceutical industry and supervisory experience. The candidate will have good written and oral communication skills. Routine interaction with other groups is required. Experience in the areas of Quality Control, method validation, and/or GMP lab work are required. Please send curriculum vitae and list of references to: ScienStaff, Inc. Attn: Dr. David W. Walters, Ph.D. Senior Scientific Recruiter 7007 Gulf Freeway, Suite 239 Houston, TX 77087 No phone or FAX calls, please. David W. Walters, Ph.D. Senior Scientific Recruiter ScienStaff, Inc. 7007 Gulf Freeway, Suite 239 Houston, Texas 77087 Phone: 713-640-1929 e-mail: ssihouston@aol.com From owner-diagnostics@net.bio.net Sun Feb 16 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Ian Mackay Newsgroups: bionet.diagnostics Subject: Virology Down Under Date: 17 Feb 1997 01:37:40 -0800 Organization: University of Queensland Lines: 26 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5e98t4$n6g@net.bio.net> NNTP-Posting-Host: net.bio.net Dear All, I invite you to visit a newly developing homepage (see URL below). While you are there, please register and become part of a database for the dissemination of methods and general knowledge in the area of virology and many of its associated fields. Whether you are a student, a senior researcher, a routine clinical scientist or some other member of the bioscientific community (not working only in virology!), by adding your details to the database, you will be a part of an informal WWW site, to make the search for experts in your field more simple, and central. Any comments are welcome and a moment of your time to "Register" would be greatly appreciated. With thanks, Ian Ian Mackay Clinical Virology Research Unit / Gene Therapy Unit Sir Albert Sakzewski Virus Research Centre Royal Children's Hospital Brisbane AUSTRALIA eMail: svimacka@dingo.uq.edu.au URL: http://www.uq.edu.au/~svimacka From owner-diagnostics@net.bio.net Sun Feb 16 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Ssihouston Newsgroups: bionet.diagnostics Subject: JOB - Clinical Research Assoc., Therapeutics - Houston Date: 17 Feb 1997 01:57:04 -0800 Organization: AOL http://www.aol.com Lines: 56 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5e9a1g$ppt@net.bio.net> NNTP-Posting-Host: net.bio.net POSITION SUMMARY This Senior Clinical Research Associate will be responsible for the administration and monitoring of clinical trials for two developmental therapeutics; an antineoplastic and an HIV therapeutic. The successful candidate will have both protocol development experience and medical report experience as well as management, administrative and supervisory experience. Specific responsibilities include the management and supervision of more junior CRAs, protocol development, institutional and physician relations, clinical trial monitoring and the coordination of various in-house activities such a medical report writing. The ideal candidate will have both computer literacy, public relations and public presentation skills and project management skills. A minimum of 3 years of directly relevant experience is required, however, five years would be preferred. PRINCIPLE RESPONSIBILITIES =B7 Administration of clinical trials for two developmental therapeutic agents. =B7 Clinical trial protocol development. =B7 Medical report writing. =B7 Institutional and physician relations. =B7 Planning of the activities of and supervision of two more junior CRAs. =B7 Coordination of in-house activities such as report writing and presentations. =B7 Interaction with and presentations to corporate partners. REQUIRED QUALIFICATIONS: =B7 Bachelor's of Arts or Science Degree (or higher) from an accredited, four-year university. Advanced degree is preferred (M.S., Ph.D. or M.D.). =B7 Minimum of 2 years of directly relevant work experience in monitoring and administering clinical trials. Five years of experience is preferred. =B7 Excellent interpersonal skills, especially as they relate to the interaction with clinicians, facility administrators, investors and corporate partners. =B7 Computer literacy with PC systems using Microsoft Windows 3.1 and Windows `95 operating systems and extensive experience with PC based report writing. =B7 Willingness to travel at least 50% of the time. PREFERRED QUALIFICATIONS: =B7 Computer literacy with spreadsheets and databases (Microsoft Access). =B7 Proficiency with both written and spoken Spanish. =B7 Experience in an identical position with a major, domestic pharmaceutical company. David W. Walters, Ph.D. Senior Scientific Recruiter ScienStaff, Inc. 7007 Gulf Freeway, Suite 239 Houston, Texas 77087 Phone: 713-640-1929 e-mail: ssihouston@aol.com From owner-diagnostics@net.bio.net Mon Feb 17 22:00:00 1997 Path: biosci!biosci!not-for-mail From: SCOTTC COATES Newsgroups: bionet.diagnostics Subject: Technical Coordinator / Program Coordinator Date: 18 Feb 1997 01:35:20 -0800 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 32 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5ebt4o$sdg@net.bio.net> NNTP-Posting-Host: net.bio.net AOAC INTERNATIONAL, an internationally active non-profit scientific & educational association in the field of chemical & microbiological analysis and laboratory management seeks two creative, innovative, efficient, goal-oriented individuals. One Technical Coordinator position is available for coordinating the review and evaluation of analytical methods, and one Program Coordinator position is available for developing and supervising AOAC programs. Both positions require a thorough understanding of analytical methodology and quality assurance principles. A minimum of a bachelor's degree in chemistry or microbiology or related scientific field is required with work experience related to the analytical chemistry or microbiology; knowledge of basic concepts, trends, and vocabulary of scientific methods development and laboratory operations; knowledge of basic concepts of statistical analysis; demonstrated oral and written communications skills; computer skills in word processing, spreadsheet, and database applications; and project management experience. Competitive salaries; excellent benefits, nice well-located, modern offices. Send, fax or mail letter of application, resume, and salary requirements to: AOAC INTERNATIONAL 481 N Frederick Ave. Gaithersburg, MD, 20877-2417 Attn.: Admin. Services Mgr. Fax 301-924-7089 From owner-diagnostics@net.bio.net Tue Feb 18 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Mingzhong Chen Newsgroups: bionet.diagnostics Subject: DNA Fingerprinting Kit Date: 19 Feb 1997 01:18:22 -0800 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 11 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5eeggu$spo@net.bio.net> NNTP-Posting-Host: net.bio.net Hi, I am looking for some information about DNA fingerprinting kit. Hope it is commercially available. Any help would be great appreciated. Mingzhong Chen Molecular diagnostics Lab CMMC Chicago --------------------- E-mail: mzchen@valise.com From owner-diagnostics@net.bio.net Tue Feb 18 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Kevin O'Donnell Newsgroups: bionet.diagnostics Subject: PCR Licensing for Crop Diagnostics Date: 19 Feb 1997 08:09:37 -0800 Organization: Scottish Agricultural Science Agency Lines: 40 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5ef8k1$fho@net.bio.net> NNTP-Posting-Host: net.bio.net Dear Colleagues, I recently contacted Hoffman la Roche, the holders of the PCR patent, with a view to obtaining a license at some future date, for assays being developed in my laboratory. Much to my surprise, I received a reply not from Roche but from Perkin-Elmer, informing me that they have obtained the rights to licence agricultural applications of PCR from Roche. What shocked me however, were the conditions that pekin elmer are offering: 1) A 10,000 USD one-off payment AND 2) A 15% royalty based on the *cost* of the assay. From my point of view as a scientist with a few small uses in mind for PCR such terms are best described as 'punitive'. It is worth bearing in mind that the royalty charged by roche on tests used in the UK's National Health Service is only 9%. This leaves us in the, IMO, absurd position where it would cost more to test a potato tuber for PVY than it costs to test a blood sample for HIV. I am sure that many other scientists currently publishing PCR assays in the journals will be in a similar position, and I wondered if any cared to comment on Perkin Elmer's conditions and the effect they would have on their work. For my own part, I have now shifted resources towards developing alternative nucleic acid amplification methods, since I see little point in developing assays that I will not be able to afford to use! Dr Kevin O'Donnell Diagnostics and Molecular Biology SASA Edinburgh From owner-diagnostics@net.bio.net Tue Feb 18 22:00:00 1997 Path: biosci!biosci!not-for-mail From: William Chernoff Newsgroups: bionet.diagnostics Subject: DNA "fingerprinting" Date: 19 Feb 1997 01:18:05 -0800 Organization: Computer Science, University of B.C., Vancouver, B.C., Canada Lines: 5 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5eeggd$soc@net.bio.net> NNTP-Posting-Host: net.bio.net Can someone please recommned a book on DNA fingerprinting? need basic info for a non-biologist. Bill Chernoff chernoff@cs.ubc.ca From owner-diagnostics@net.bio.net Wed Feb 19 22:00:00 1997 Path: biosci!biosci!not-for-mail From: "John J. Macey" Newsgroups: bionet.diagnostics Subject: Asia - Pacific Biotech / Medical Products Manager Date: 20 Feb 1997 01:38:11 -0800 Organization: TMnet Malaysia Lines: 14 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5eh623$hnu@net.bio.net> NNTP-Posting-Host: net.bio.net Dear Employment Executive, Trained and experienced Asia Pacific Biotech / Medical Products Manager seeks Region wide management / marketing position. Should your organization be looking to expand its business or manage the Asia Pacific market potential please see my WWW Home Page at the URL below. Thanks in advance for your consideration. -- John J. Macey email: jjmacey@msn.com Home Page: http://home.pacific.net.sg/~andrewr/jjmacey From owner-diagnostics@net.bio.net Thu Feb 20 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Peter Witzel Newsgroups: bionet.diagnostics Subject: MPN program - mpnsw.arj (0/2) Date: 21 Feb 1997 01:52:45 -0800 Organization: commercial link systems Lines: 9 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5ejr9d$1fn@net.bio.net> NNTP-Posting-Host: net.bio.net This is my shareware program to calculate MPN numbers with your MS-Dos PC. You can read in ASCII files, have the program automatically read the extinktion, for up to 12 parallels/dilutions! Get rid of those nasty tables! Check the program out!! Comments to Peter.Witzel@kiel.netsurf.de From owner-diagnostics@net.bio.net Sun Feb 23 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Kevin Shreder Newsgroups: bionet.diagnostics Subject: The Antibody Resource Page Date: 24 Feb 1997 01:33:31 -0800 Organization: Antibody Resource Page Lines: 33 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5ern9b$m6r@net.bio.net> NNTP-Posting-Host: net.bio.net The Antibody Resource Page (ARP) has recently been updated and given a new user-friendly look. The ARP is divided up into 7 sections: 1. Educational Resources - links to pages on antibodies that will interest the novice and expert alike 2. Online Databanks and Databases - links to scientific databases in the area of sequence analysis and hybridoma work 3. Online Journals 4. How to Find an Antibody - a section for ways to find commercial sources (online or otherwise) of antibodies. If you are a researcher who works with antibodies, you cannot afford to miss this section. 5. Online Companies - a large list of online companies (over 75) that sell antibodies or antibody related products. There is also a section for companies that are not online. 6. Miscellaneous - links to various immunological and biotechnology webpages 7. Antibody Gallery - a new addition to the ARP. This is a section where researchers can donate pictures of antibodies for educational purposes. If you have something to donate, please contact me. The ARP is designed for both beginners and experts who are looking for information about antibodies. I am always looking for new links, so if you know of something, please contact me. Or just contact me to let me know what you think of the page! The URL for the Antibody Resource Page is: http://www-chem.ucsd.edu/Faculty/goodman/antibody.html/abpage.html Kevin Shreder, Ph.D. kshreder@znet.com From owner-diagnostics@net.bio.net Sun Feb 23 22:00:00 1997 Path: biosci!biosci!not-for-mail From: "Marco Radice, PhD" Newsgroups: bionet.diagnostics Subject: Help: chick embryo antibodies Date: 24 Feb 1997 01:37:29 -0800 Organization: University of Padova Lines: 18 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5erngp$mdq@net.bio.net> NNTP-Posting-Host: net.bio.net Hallo bio-netters. I am actually trying to charcterize the ECM production of chick embryo sternal chondrocytes but I have not found a supplier of antibodies against avian collagen type II. Any hint? Thank you a lot in advance. Marco Radice Inst. of Histology and Embryology Univ. of Padova via G. Colombo, 3 I-35121 Padova (Italy) fax#++39-49-8276079 e-mail: radice@inca.dei.unipd.it From owner-diagnostics@net.bio.net Wed Feb 26 22:00:00 1997 Path: biosci!biosci!not-for-mail From: Kevin O'Donnell Newsgroups: bionet.diagnostics Subject: (Fwd) Re: MPN program - mpnsw.arj (0/2) Date: 27 Feb 1997 03:38:04 -0800 Organization: Scottish Agricultural Science Agency Lines: 12 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <5f3rms$d4n@net.bio.net> NNTP-Posting-Host: net.bio.net > I'll forward this post and maybe you'd > like to send a URL for people to obtain the programme? Thank you. Maybe add this WWW Url I just established: File can be downloaded on http://homes.cls.de/users/p/peter/mpnsw.arj The program is good for calculating MPN (Most Propable Numbers) Thank you. Peter.Witzel@kiel.netsurf.de http://homes.cls.de/users/p/peter/index.htm Travel, car-rental and much more funstuff!